AAPGAscentage Pharma Group Inc.Signing up patients
Global Trial in APG2575 for Patients With CLL/SLL
CLL/SLL
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 3
- Patients
- 400 (planned)
- Started
- Dec 20, 2023
- Main results expected
- Dec 31, 2026
- Fully finished
- Oct 31, 2027
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
PFS
Measured over: 12 months
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT06104566 · record last updated 2026-06-18 · checked 2026-11-09 15:47 UTC